The investment was based on the Psychedelic ETF that launched yesterday. The same investors also did similar deals with the other companies included in the ETF. Also not sure how all you geniuses expect Revive to fund all their Trials and Research when they are literally generating $0.00 revenue. With this 40M sale the OS goes to 300M which for a Pharmaceutical company is low. They also just added two more Trial sites which indicates that the Trial is expanding. Not sure why a company would be expanding it's Trials if it wasn't showing good results!?!